Clinical trial
Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET): Intensive vs Liberalized Phosphate Control in Hemodialysis Recipients
NCT01994733 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET): Intensive vs Liberalized Phosphate Control in Hemodialysis Recipients
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- April 30, 2015
- Enrollment
- 104 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease